The Role of RWE in Supplemental or Conditional Approvals

Real World Evidence (RWE) has become increasingly important in supporting supplemental or conditional drug approvals. Where is the space headed?

Read ClearView’s summary of the new FDA framework for RWE and its role in the recent approvals of novel oncology therapies.

CLEARVIEW HEALTHCARE PARTNERS® is a registered trademark of ClearView Healthcare Partners, LLC in the United States, the UK, Switzerland, the European Union, and various other countries. All Rights Reserved.